Lazard Asset Management Portfolio holdings
AUM
$72.7B
This Quarter Return
+5.88%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$47.8B
AUM Growth
+$47.8B
(+6.9%)
Cap. Flow
+$1.78B
Cap. Flow
% of AUM
3.71%
Top 10 Holdings %
Top 10 Hldgs %
17.74%
Holding
1,161
New
131
Increased
295
Reduced
302
Closed
143
Top Buys
| 1 |
Apple
AAPL
|
$782M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$539M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$290M |
| 4 |
CSX Corp
CSX
|
$201M |
| 5 |
Ally Financial
ALLY
|
$195M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$279M |
| 2 |
CVS Health
CVS
|
$239M |
| 3 |
McKesson
MCK
|
$210M |
| 4 |
Mastercard
MA
|
$204M |
| 5 |
Molson Coors Class B
TAP
|
$197M |
Sector Composition
| 1 | Healthcare | 14.83% |
| 2 | Communication Services | 13.94% |
| 3 | Technology | 12.75% |
| 4 | Financials | 10.45% |
| 5 | Energy | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sysco
SYY
$38.5B
| $437M | 0.91% | 11,676,115 +1,670,067 | +17% | +$62.5M |
|
27
APA Corp
APA
$8.31B
| $425M | 0.89% | 4,221,649 -351,711 | -8% | -$35.4M |
|
28
UnitedHealth
UNH
$281B
| $419M | 0.88% | 5,125,381 -136,794 | -3% | -$11.2M |
|
29
PG&E
PCG
$33.6B
| $418M | 0.87% | 8,700,791 +2,509,623 | +41% | +$121M |
|
30
Vale
VALE
$43.9B
| $416M | 0.87% | 31,436,688 +367,965 | +1% | +$4.87M |
|
31
SPDR S&P 500 ETF Trust
SPY
$658B
| $412M | 0.86% | 2,104,560 +283,969 | +16% | +$55.6M |
|
32
Citigroup
C
$178B
| $408M | 0.85% | 8,653,427 +812,260 | +10% | +$38.3M |
|
33
American Express
AXP
$231B
| $402M | 0.84% | 4,237,512 -32,136 | -0.8% | -$3.05M |
|
34
Eli Lilly
LLY
$657B
| $400M | 0.84% | 6,434,958 -10,854 | -0.2% | -$675K |
|
35
Honeywell
HON
$139B
| $394M | 0.82% | 4,233,842 -102,148 | -2% | -$9.49M |
|
36
Baxter International
BAX
$12.7B
| $374M | 0.78% | 5,170,918 -122,559 | -2% | -$8.86M |
|
|
MON
37
DELISTED
Monsanto Co
MON
| $368M | 0.77% | 2,949,268 -105,522 | -3% | -$13.2M |
|
38
CEMIG Preferred Shares
CIG
$5.81B
| $367M | 0.77% | 45,893,749 +9,288,580 | +25% | +$74.2M |
|
39
Oracle
ORCL
$635B
| $318M | 0.67% | 7,851,983 -636,639 | -7% | -$25.8M |
|
40
Norfolk Southern
NSC
$62.8B
| $315M | 0.66% | 3,057,985 +1,349,000 | +79% | +$139M |
|
41
Amgen
AMGN
$155B
| $304M | 0.64% | 2,566,790 -91,633 | -3% | -$10.8M |
|
42
Johnson & Johnson
JNJ
$427B
| $301M | 0.63% | 2,876,253 -26,410 | -0.9% | -$2.76M |
|
|
CFN
43
DELISTED
CAREFUSION CORPORATION
CFN
| $300M | 0.63% | 6,754,802 -535,386 | -7% | -$23.7M |
|
44
Transocean
RIG
$2.86B
| $299M | 0.62% | 6,629,266 +111,314 | +2% | +$5.01M |
|
|
45
CVS Health
CVS
$92.8B
| $298M | 0.62% | 3,960,223 -3,171,687 | -44% | -$239M |
|
46
EOG Resources
EOG
$68.2B
| $298M | 0.62% | 2,546,128 +1,221,879 | +92% | +$143M |
|
47
Exxon Mobil
XOM
$487B
| $294M | 0.61% | 2,919,550 -202,606 | -6% | -$20.4M |
|
48
Occidental Petroleum
OXY
$46.9B
| $291M | 0.61% | 2,831,612 -43,450 | -2% | -$4.46M |
|
49
Devon Energy
DVN
$22.9B
| $290M | 0.61% | 3,656,707 -147,267 | -4% | -$11.7M |
|
50
Intercontinental Exchange
ICE
$101B
| $290M | 0.61% | 1,535,705 +183,096 | +14% | +$34.6M |
|